Patents by Inventor Eric Francis Morand

Eric Francis Morand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of inflammatory diseases
    Patent number: 7863313
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as a part of combination therapy. Novel compounds of formula (I) are also provided for.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: January 4, 2011
    Assignee: Cortical PTY LTD
    Inventors: Eric Francis Morand, Magdy Naguib Iskander, Colin Edward Skene
  • Therapeutic Molecules and Methods-1
    Publication number: 20100323999
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) as defined herein, is provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as part of a combination therapy. Novel heterocyclic compounds are also provided for.
    Type: Application
    Filed: March 22, 2010
    Publication date: December 23, 2010
    Inventors: Eric Francis Morand, Magdy Naguib Iskander, Basil Danylec
  • Novel Methods for the Treatment of Inflammatory Diseases
    Publication number: 20100324001
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as a part of combination therapy. Novel compounds of formula (I) are also provided for.
    Type: Application
    Filed: June 30, 2010
    Publication date: December 23, 2010
    Applicant: Cortical Pty LTD
    Inventors: Eric Francis Morand, Magdy Naguib Iskander, Colin Edward Skene
  • Therapeutic molecules and methods-1
    Patent number: 7709514
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) as defined herein, is provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as part of a combination therapy. Novel heterocyclic compounds are also provided for.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: May 4, 2010
    Assignee: Cortical Pty Ltd
    Inventors: Eric Francis Morand, Magdy Naguib Iskander, Basil Danylec
  • MIF Inhibitors
    Publication number: 20090130165
    Abstract: The present invention relates to the use of specific benzimidazolone analogues and derivatives to inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF), and diseases or conditions wherein MIF cytokine or biological activity is implicated. Novel benzimidazole analogues and derivatives are also provided.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 21, 2009
    Inventors: Eric Francis Morand, Colin Edward Skene, Peter Mark Tapley, Xinhua Li, Thomas H. Jozefiak